Abbott said that an ongoing multisite clinical study indicated that its rapid COVID-19 test was accurate when detecting the virus nearly 95% of the time. Abbott said that an ongoing multisite ...
Excluding COVID-19 testing-related sales, growth in Rapid Diagnostics was driven by strong demand for Abbott’s portfolio of respiratory disease tests. Guidance: Abbott projects full-year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback